Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 1:09 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1417–1440 of 2,513 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: RAPID Clear all

Conditions: Urinary Tract Infections, Bladder, Neurogenic
Interventions: Not listed
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 338 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Non-small Cell Lung Cancer (NSCLC)
Interventions: ROSE (presence of cytotech) & liquid prep, NO-ROSE (absence of cytotech) & liquid prep, ROSE (presence of cytotech) & tissue clot sample, NO-ROSE (absence of cytotech) & tissue clot sample; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 349 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 4
States / cities: Chicago, Illinois • Baltimore, Maryland • Charleston, South Carolina

Conditions: Rapid Shallow Breathing
Interventions: Not listed
Lead sponsor: Atlantic Health System; Other
Eligibility: Not listed
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Morristown, New Jersey

Conditions: Congenital Lactic Acidosis
Interventions: Dichloroacetate (DCA), Genetic Marker on Chromosome 14q24.3; Drug · Genetic
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 50 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Mental Disorder
Interventions: Critical Time Intervention for Young Adults with Mental Health conditions; Behavioral
Lead sponsor: University of Houston; Other
Eligibility: 18 Years to 24 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Hypertension
Interventions: Enhanced External Counterpulsation; Device
Lead sponsor: Albert Einstein Healthcare Network; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Castration-resistant Prostate Cancer, Stage IV Prostate Cancer
Interventions: abiraterone acetate; Drug
Lead sponsor: University of Chicago; Other
Eligibility: Male only
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 5
States / cities: Atlanta, Georgia • Chicago, Illinois • Evanston, Illinois + 2 more

Conditions: Depression
Interventions: Ketamine, Diphenhydramine; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 2
States / cities: New York, New York

Conditions: Type 1 Diabetes Mellitus
Interventions: Insulin glargine, 300 U/ml, Insulin degludec, 100U/ml, Background therapy: Rapid acting insulin analogs; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 343 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Bicep Tendinitis, Biceps; Tenosynovitis, Biceps Tendon Disorder
Interventions: Long head of Biceps Tenodesis; Procedure
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 3
States / cities: St Louis, Missouri

Conditions: Type 2 Diabetes Mellitus
Interventions: Raspberries; Other
Lead sponsor: Oklahoma State University; Other
Eligibility: 21 Years to 60 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Stillwater, Oklahoma

Conditions: Infection, Skin and Subcutaneous Tissue Bacterial Infections, Healthcare-associated Infection, Infection Due to Resistant Bacteria
Interventions: Not listed
Lead sponsor: Connie Price; Other
Eligibility: 18 Years and older
Enrollment: 2,298 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 3
States / cities: Denver, Colorado • Washington D.C., District of Columbia

Conditions: Adolescent Idiopathic Scoliosis, Respiratory Depression, Postoperative Pain
Interventions: pharmacokinetic simulation; Other
Lead sponsor: University of Florida; Other
Eligibility: 10 Years to 18 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Tuberculosis
Interventions: PA-824 1000 mg; Drug
Lead sponsor: Global Alliance for TB Drug Development; Other
Eligibility: 19 Years to 50 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Breast Cancer
Interventions: Not listed
Lead sponsor: Menssana Research, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 4
States / cities: Los Angeles, California • Montclair, New Jersey • Newark, New Jersey + 1 more

Conditions: Pneumonia, Hematologic Malignancy, Pseudomonas Aeruginosa Infection, Bacteremia, Hematopoietic Stem Cell Transplant (HSCT)
Interventions: Ceftolozane / Tazobactam Injection; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Lupus Nephritis
Interventions: VIB4920, Placebo for VIB4920; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 17
States / cities: La Jolla, California • Los Angeles, California • Orange, California + 13 more

Conditions: Healthy
Interventions: [¹⁴C]-LY3484356, LY3484356, [¹⁴C]-LY3484356 (IV); Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Multi-drug Resistant Tuberculosis
Interventions: Pretomanid; Drug
Lead sponsor: Global Alliance for TB Drug Development; Other
Eligibility: 19 Years to 50 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Diabetes
Interventions: Ramipril, Candesartan cilexetil, Allopurinol; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 21 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Odontogenic Deep Space Neck Infection
Interventions: Target Enriched Multiplex PCR (TEM- PCR), Microbial culture; Diagnostic Test
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Epilepsy, SUDEP
Interventions: 6% Carbon dioxide/50% oxygen/balance nitrogen mixture; Other
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 99 Years
Enrollment: 335 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2029
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: High Risk Pregnancy, Congenital Heart Disease, Fetal Hydrops, Twin Monochorionic Monoamniotic Placenta, Gastroschisis, Fetal Demise, Stillbirth, Fetal Arrhythmia, Long QT Syndrome, Intrauterine Fetal Death, Sudden Infant Death, Pregnancy Loss, Twin Twin Transfusion Syndrome, Birth Defect, Fetal Cardiac Anomaly, Fetal Cardiac Disorder, Fetal Death, Brugada Syndrome, Fetal Tachycardia
Interventions: Fetal Magnetocardiogram and Neonatal Electrocardiogram, Substudy only: Maternal/Infant Pharmacogenomic assessment postnatally; Diagnostic Test · Genetic
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2028
U.S. locations: 2
States / cities: Madison, Wisconsin • Milwaukee, Wisconsin

Conditions: HIV
Interventions: Rapid HIV testing, Referral for HIV testing; Other
Lead sponsor: Boston University; Other
Eligibility: 18 Years and older
Enrollment: 6,715 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2028
U.S. locations: 4
States / cities: Boston, Massachusetts • Dorchester, Massachusetts

Search by objective public record fields.

A Biochip for Rapid Diagnosis of Complicated Urinary Tract Infection

ROSE for Improved Molecular Marker Testing Via EBUS

Prediction of Weaning Outcomes by Using Rate of Change of Rapid Shallow Breathing Index

Pharmacotoxicology of Trichloroethylene Metabolites

Adaptation of Critical Time Intervention for Young Adults With MH Challenges

Role of Enhanced External Counterpulsation (EECP) Therapy in Patients With Resistant Hypertension

Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer

Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients

Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients

A Prospective Study Comparing Suture Anchor and Soft Tissue Pectoralis Major Tendon Techniques for Biceps Tenodesis

Raspberries and Postprandial Metabolism

Study of Accuracy of New Diagnostic Technology to Determine Guide Rapid Antibiotic Treatment for Serious Infections

Anesthetic Optimization in Scoliosis Surgery

Food Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects

A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer

Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation

VIBRANT: VIB4920 for Active Lupus Nephritis

A Study of [¹⁴C]-LY3484356 in Healthy Female Participants

Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid

Impact of Diabetes on Left Ventricular Remodeling

Diagnostic Modalities for Severe Odontogenic Infections Using Rapid, Target Enriched Multiplex PCR (TEM- PCR) by Diatherix

Carbon Dioxide (CO2) Chemosensitivity and SUDEP

Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise

HIV Testing in Community Health Center Dental Clinics